Approaches to synthesis of ([1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids as potential anti-inflammators

Despite their high efficacy NSAIDs have significant side effects due to non-selective inhibition of COX-1 and COX-2. Due to this, medical chemists still pay considerable attention to their design and synthesis, in particular the creation of hybrid molecules that combine in their structure a fragment...

Full description

Saved in:
Bibliographic Details
Published inFarmacevtičnij žurnal Vol. 3; no. 3; pp. 44 - 54
Main Author Красовська, Н. І.
Format Journal Article
LanguageEnglish
Ukrainian
Published The State Expert Center of the Ministry of Health of Ukraine 29.06.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Despite their high efficacy NSAIDs have significant side effects due to non-selective inhibition of COX-1 and COX-2. Due to this, medical chemists still pay considerable attention to their design and synthesis, in particular the creation of hybrid molecules that combine in their structure a fragment with anti-inflammatory activity and the quinazoline heterocycle. The aim of the present study is to develop methods for the synthesis of [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids as potential anti-inflammatory agents. Quinazolin-4(3H)-ylidene)hydrazides (hydrazones) of benzenedicarboxylic acids, their esters, products of their heterocyclization and nucleophilic degradation were the subjects of the study. The structure of the synthesized compounds was confirmed by elemental analysis and NMR spectroscopy. Anti-inflammatory activity was studied in a model of acute aseptic inflammation («carrageenan test») in rats. Possibilities and limitations of synthesis of [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids and their esters via hetero­cyclization of the corresponding hydrazides and hydrazones oxidative cyclization are shown. It was found that the hydrolysis of 4-[(1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acid esters is not a preparative method for the synthesis of the target acids, due to the hydrolytic cleavage of the pyrimidine cycle. Compounds 3, 4 and 6 with moderate anti-inflammatory activity have been identified, which can be used for further structural modification. Conclusions. It was found that quinazolin-4(3H)-ylidene)hydrazides (hydrazones) of benzenedicarboxylic acids and their esters under the conditions of heterocyclization and oxidative cyclization form [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids and their esters. The synthesized compounds are carriers of anti-inflammatory activity and promising for further research.
AbstractList Despite their high efficacy NSAIDs have significant side effects due to non-selective inhibition of COX-1 and COX-2. Due to this, medical chemists still pay considerable attention to their design and synthesis, in particular the creation of hybrid molecules that combine in their structure a fragment with anti-inflammatory activity and the quinazoline heterocycle. The aim of the present study is to develop methods for the synthesis of [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids as potential anti-inflammatory agents. Quinazolin-4(3H)-ylidene)hydrazides (hydrazones) of benzenedicarboxylic acids, their esters, products of their heterocyclization and nucleophilic degradation were the subjects of the study. The structure of the synthesized compounds was confirmed by elemental analysis and NMR spectroscopy. Anti-inflammatory activity was studied in a model of acute aseptic inflammation («carrageenan test») in rats. Possibilities and limitations of synthesis of [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids and their esters via hetero­cyclization of the corresponding hydrazides and hydrazones oxidative cyclization are shown. It was found that the hydrolysis of 4-[(1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acid esters is not a preparative method for the synthesis of the target acids, due to the hydrolytic cleavage of the pyrimidine cycle. Compounds 3, 4 and 6 with moderate anti-inflammatory activity have been identified, which can be used for further structural modification. Conclusions. It was found that quinazolin-4(3H)-ylidene)hydrazides (hydrazones) of benzenedicarboxylic acids and their esters under the conditions of heterocyclization and oxidative cyclization form [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids and their esters. The synthesized compounds are carriers of anti-inflammatory activity and promising for further research.
Despite their high efficacy NSAIDs have significant side effects due to non-selective inhibition of COX-1 and COX-2. Due to this, medical chemists still pay considerable attention to their design and synthesis, in particular the creation of hybrid molecules that combine in their structure a fragment with anti-inflammatory activity and the quinazoline heterocycle. The aim of the present study is to develop methods for the synthesis of [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids as potential anti-inflammatory agents. Quinazolin-4(3H)-ylidene)hydrazides (hydrazones) of benzenedicarboxylic acids, their esters, products of their heterocyclization and nucleophilic degradation were the subjects of the study. The structure of the synthesized compounds was confirmed by elemental analysis and NMR spectroscopy. Anti-inflammatory activity was studied in a model of acute aseptic inflammation («carrageenan test») in rats. Possibilities and limitations of synthesis of [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids and their esters via hetero­cyclization of the corresponding hydrazides and hydrazones oxidative cyclization are shown. It was found that the hydrolysis of 4-[(1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acid esters is not a preparative method for the synthesis of the target acids, due to the hydrolytic cleavage of the pyrimidine cycle. Compounds 3, 4 and 6 with moderate anti-inflammatory activity have been identified, which can be used for further structural modification. Conclusions. It was found that quinazolin-4(3H)-ylidene)hydrazides (hydrazones) of benzenedicarboxylic acids and their esters under the conditions of heterocyclization and oxidative cyclization form [1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids and their esters. The synthesized compounds are carriers of anti-inflammatory activity and promising for further research.
Author Красовська, Н. І.
Author_xml – sequence: 1
  givenname: Н. І.
  orcidid: 0000-0001-5902-6596
  surname: Красовська
  fullname: Красовська, Н. І.
BookMark eNp9UU1LAzEQDaJgrf0DnvaoYGp2stlujiJ-geBFT1LCbD40sk1qEg_117tV8eBBGHjzZniP4c0B2Q0xWEKOajbnwAWcMd4uKGdiMedzgDkTO2QCbb2gsoVul0x-9_tklvMrYwyg4R2ICQnn63WKqF9srkqs8iaUsfW5iq46fqpP4bRZluTxIw5xpILq5du7D1vuAwW6GU56Gz6i1xVqb3KFuVrHYkPxOFQ4AvXBDbhaYYkpH5I9h0O2sx-cksery4eLG3p3f317cX5HNTAQtHNSusa5vmVuPF7b2oBuDGuBYasFg75uOkDTCM5RWCY0WGkdyM6gQWf5lNx--5qIr2qd_ArTRkX06msQ07PCVLwerJISat63Y7mu6bmRUnDX91Y3NTMLJkcv-PbSKeacrPv1q5n6eoDaBqy2ASuuYKRiFHV_RNoXLD6GktAP_0k_AY8rjJM
CitedBy_id crossref_primary_10_1007_s11224_023_02251_8
ContentType Journal Article
DBID AAYXX
CITATION
DOA
DOI 10.32352/0367-3057.3.22.05
DatabaseName CrossRef
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2617-9628
EndPage 54
ExternalDocumentID oai_doaj_org_article_99213b63b6f84b3d9953fbbec410d709
10_32352_0367_3057_3_22_05
GroupedDBID AAYXX
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BCNDV
CITATION
GROUPED_DOAJ
ID FETCH-LOGICAL-c2025-8f99f4ffb60f036ce1d2c4d0620a6c502b1482ad4533a5e05c2e9ef298dadafe3
IEDL.DBID DOA
ISSN 0367-3057
IngestDate Wed Aug 27 01:17:39 EDT 2025
Tue Jul 01 00:26:41 EDT 2025
Thu Apr 24 22:58:18 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
Ukrainian
License http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2025-8f99f4ffb60f036ce1d2c4d0620a6c502b1482ad4533a5e05c2e9ef298dadafe3
ORCID 0000-0001-5902-6596
OpenAccessLink https://doaj.org/article/99213b63b6f84b3d9953fbbec410d709
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_99213b63b6f84b3d9953fbbec410d709
crossref_primary_10_32352_0367_3057_3_22_05
crossref_citationtrail_10_32352_0367_3057_3_22_05
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-06-29
PublicationDateYYYYMMDD 2022-06-29
PublicationDate_xml – month: 06
  year: 2022
  text: 2022-06-29
  day: 29
PublicationDecade 2020
PublicationTitle Farmacevtičnij žurnal
PublicationYear 2022
Publisher The State Expert Center of the Ministry of Health of Ukraine
Publisher_xml – name: The State Expert Center of the Ministry of Health of Ukraine
SSID ssj0002243825
Score 2.1872413
Snippet Despite their high efficacy NSAIDs have significant side effects due to non-selective inhibition of COX-1 and COX-2. Due to this, medical chemists still pay...
SourceID doaj
crossref
SourceType Open Website
Enrichment Source
Index Database
StartPage 44
SubjectTerms 4]triazolo
5-c]-quіnazolin-2-yl)benzoic acids
anti-inflammatory activity
dimroth rearrangement
heterocyclization
oxidative cyclization
spectral characteristics
Title Approaches to synthesis of ([1,2,4]triazolo[1,5-c]quinazolin-2-yl)benzoic acids as potential anti-inflammators
URI https://doaj.org/article/99213b63b6f84b3d9953fbbec410d709
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS-UwEA_iyYu4frC6q-QgovjyTNOkrzmqKCIoHhSERUo-obtuq_a9w_Ovd6atz3fSi9DLhCQNmRnmF5L5DSG7EYNSMAmLWkomwZ3A52xkOudG2qita2kXr66zizt5ea_u50p94Zuwjh6427gjrUWS2gy-mEubeq1VGi38WSbcj7rUPYh5c4epvy2pC15wqe6iErwIUEmXMZMKQBxHs8ZhOhRiiLXr5qLSHHl_G2XOV8hyDw_pcbesH2Rh8m-V7N10_NLTAb39SJdqBnSP3nwwT0_XSHXcM4SHho5r2kwrgHdN2dA60v0_yUAM5AOW6XiF_iAq5h6eJ2WFclkxwaaPBzZUr3XpqHGlb6hp6FM9xgdFsCjQQcnAIMGG_uNRvVknd-dnt6cXrC-owJzAsrV51DrKGG3GI2yBC4kXTnqeCW4yp7iwyApqvAQMaFTgyomgQxQ698abGNINsljVVfhJqLFWu5B7bxUgqqDNKNfBZbniAceONknyvqGF69nGsejFYwGnjlYJBSqhQCUUaSFAVJvkcDbmqePa-LT3Cepp1hN5stsGsJ6it57iK-vZ-o5JfpElgUkRPGNC_yaL45dJ2AaoMrY7rVW-Adem4tk
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Approaches+to+synthesis+of+%28%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-c%5Dquinazolin-2-yl%29benzoic+acids+as+potential+anti-inflammators&rft.jtitle=Farmacevti%C4%8Dnij+%C5%BEurnal&rft.au=%D0%9A%D1%80%D0%B0%D1%81%D0%BE%D0%B2%D1%81%D1%8C%D0%BA%D0%B0%2C+%D0%9D.+%D0%86.&rft.date=2022-06-29&rft.issn=0367-3057&rft.eissn=2617-9628&rft.issue=3&rft.spage=44&rft.epage=54&rft_id=info:doi/10.32352%2F0367-3057.3.22.05&rft.externalDBID=n%2Fa&rft.externalDocID=10_32352_0367_3057_3_22_05
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0367-3057&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0367-3057&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0367-3057&client=summon